Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» kidney cancer
kidney cancer
Immunicum's dendritic cell therapy flunks co-primary endpoint in 'positive' PhII
Endpoints
Thu, 08/29/19 - 10:31 am
Immunicum
immune priming
metastatic kidney cancer
kidney cancer
clinical trials
Exelixis Hits Blockbuster Status
Motley Fool
Mon, 08/5/19 - 10:45 am
Exelixis
cabozantinib
Cabometx
kidney cancer
liver cancer
Cometriq
thyroid cancer
Merck puts $1B more into oncology, with kidney cancer a focus
Biopharma Dive
Wed, 05/22/19 - 09:52 am
Merck
kidney cancer
M&A
Peloton Therapeutics
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer
Xconomy
Mon, 04/22/19 - 11:11 am
Merck
FDA
Keytruda
kidney cancer
advanced renal cell carcinoma
Inlyta
Pfizer's Forgotten Cancer Pill Is About to Become Its Next Blockbuster
Motley Fool
Tue, 02/19/19 - 12:20 pm
Pfizer
Inlyta
kidney cancer
Merck
Keytruda
Merck, Pfizer drug combo extends kidney cancer survival -study
Yahoo/Reuters
Sun, 02/17/19 - 11:57 pm
Merck
Pfizer
kidney cancer
Keytruda
Inlyta
Sutent
Exelixis Proves Being Second Can Work Out Well
Motley Fool
Wed, 02/13/19 - 05:04 pm
Exelixis
Bristol-Myers Squibb
Cabometyx
kidney cancer
Aveo stock plunges after delay in FDA approval submission for cancer drug
Bizjournals
Fri, 02/1/19 - 12:16 am
Aveo Oncology
kidney cancer
FDA
tivozanib
advanced renal cell carcinoma
Roche yanks Tecentriq kidney cancer applications as Merck, Pfizer speed toward approvals
Fierce Pharma
Tue, 11/20/18 - 12:15 pm
Roche
Merck
Pfizer
Tecentriq
kidney cancer
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Tue, 11/6/18 - 09:34 am
Exelixis
earnings
kidney cancer
Cabometyx
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Sun, 10/21/18 - 11:28 pm
Pfizer
Bristol-Myers Squibb
kidney cancer
Bavencio
Merck's Keytruda, ready to challenge Bristol-Myers Squibb, posts kidney cancer combination win
Fierce Pharma
Thu, 10/18/18 - 01:07 pm
Merck
Keytruda
kidney cancer
Pfizer
Inlyta
Sutent
Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer
Yahoo/Reuters
Tue, 09/11/18 - 09:28 am
Merck KGaA
Bavencio
Pfizer
kidney cancer
Inlyta
Exelixis Gets the Patients Eventually
Motley Fool
Mon, 08/6/18 - 11:47 pm
Exelixis
kidney cancer
renal cell carcinoma
Cabometyx
Eisai's Lenvima posts big growth numbers as Merck collaboration rolls into action
Fierce Pharma
Fri, 08/3/18 - 11:33 am
Merck
Eisai
Lenvima
kidney cancer
thyroid cancer
Bristol's Opdivo-Yervoy duo snares a quick FDA nod in first-line kidney cancer
Fierce Pharma
Mon, 04/16/18 - 11:36 pm
Bristol-Myers Squibb
Opdivo
Yervoy
kidney cancer
Pfizer strikes out on Inlyta expansion bid with postsurgery kidney cancer failure
Fierce Pharma
Thu, 04/12/18 - 11:46 am
Pfizer
renal cell carcinoma
kidney cancer
Inlyta
Novartis offloads failed cancer drug to Oncology Venture
Fierce Biotech
Wed, 04/11/18 - 09:32 am
Novartis
Oncology Venture
dovitinib
kidney cancer
cancer
Roche hails another PhIII win on Tecentriq combo, reports promising kidney cancer data
Endpoints
Mon, 02/5/18 - 07:07 pm
Roche
Tecentriq
kidney cancer
Merck & Co. and Eisai seek to undermine BMS’ position in kidney cancer treatment sector
GoinPharma
Wed, 01/17/18 - 10:05 am
Eisai
Merck
Bristol-Myers Squibb
kidney cancer
Keytruda
Lenvima
Opdivo
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »